Cervical cancer vaccine bound for clinic; Businesses warned to prepare for vax campaigns;

Vaccine Research

VGX Pharmaceuticals says that the FDA has accepted its IND for an experimental DNA vaccine for cervical cancer. VGX-3100 will go into Phase I in the third quarter. Story

Researchers at the University of Pennsylvania School of Medicine have developed a new technique that tricks the human immune system to respond against multiple strains of bird flu. Release

Sinovac Biotech has begun to recruit patients for a mid-stage study of its bird flu vaccine. Report

Genetically engineered yeast has produced an anti-tumor response in mice. Story

Monash University scientists have started clinical trials to find a successful vaccine against footrot in sheep. Report

Vaccine market

Experts are warning companies in the U.S. to start preparing now for any upcoming flu vaccination programs. Release

WellPoint, one of the largest insurers in the U.S., says that it will reimburse for the new rotavirus vaccine Rotarix. Report

Physicians in the U.K. are being warned of a shortage of vaccines for children. Story

Suggested Articles

GSK has formed several collaborations across the globe that will use its AS03 adjuvant to develop vaccines against the novel coronavirus.

Former FDA Commissioner Scott Gottlieb says 40% of the population needs to be vaccinated to achieve COVID-19 herd immunity.

CanSino Bio, Moderna and a collaboration between Oxford Univeristy and AstraZeneca are frontrunners, but they all face hurdles shared and unique.